Functional Regulation of Tissue Plasminogen Activator on the Surface of Vascular Smooth Muscle Cells by the Type-II Transmembrane Protein p63 (CKAP4)

• Published in: The Journal of biological chemistry Vol. 278; no. 43; pp. 42679 - 42685
• Main Authors: Razzaq, Tahir M., Bass, Rosemary, Vines, David J., Werner, Finn, Whawell, Simon A., Ellis, Vincent
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 24.10.2003; American Society for Biochemistry and Molecular Biology
• Subjects: Animals; Antibodies, Monoclonal - biosynthesis; Antibodies, Monoclonal - pharmacology; Aorta - cytology; Endoplasmic Reticulum - chemistry; Humans; Mass Spectrometry; Membrane Proteins - analysis; Membrane Proteins - immunology; Membrane Proteins - physiology; Muscle, Smooth, Vascular - chemistry; Muscle, Smooth, Vascular - cytology; Muscle, Smooth, Vascular - metabolism; Mutation; Plasminogen - metabolism; Protein Binding; Rats; Tissue Plasminogen Activator - metabolism
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M305695200

We have demonstrated that tissue plasminogen activator (tPA) binds specifically to human vascular smooth muscle cells (VSMC) in a functionally relevant manner, both increasing plasminogen activation and decreasing tPA inhibition (Ellis, V., and Whawell, S. A. (1997) Blood 90, 2312-2322; Werner, F., Razzaq, T. M., and Ellis, V. (1999) J. Biol. Chem. 274, 21555-21561). To further understand this system we have now identified and characterized the protein responsible for this binding. Rat VSMC were surface-labeled with 125I, and cell lysates were subjected to an affinity chromatography scheme based on the previously identified tPA binding characteristics. A single radiolabeled protein of 63 kDa bound specifically and was eluted at low pH. This protein was isolated from large scale preparations of VSMC and unambiguously identified as the rat homologue of the human type-II transmembrane protein p63 (CKAP4) by matrix-assisted laser desorption ionization and nano-electrospray tandem mass spectrometry of tryptic fragments. In confirmation of this, a monoclonal antibody raised against authentic human p63 recognized the isolated protein in Western blotting. Immunofluorescence microscopy demonstrated that p63 was located principally in the endoplasmic reticulum but was also detected in significant quantities on the surface of human VSMC. In support of the hypothesis that p63 is the functional tPA binding site on VSMC, an anti-p63 monoclonal antibody was found to block tPA binding. Furthermore, heterologous expression of an N-terminally truncated mutant of p63, which targets exclusively to the plasma membrane, led to an increase in tPA-catalyzed plasminogen activation. Therefore, p63 on the surface of VSMC may contribute to the functional regulation of the plasminogen activation system in the vessel wall.